return to news
  1. Piramal Pharma, CARE Ratings, HUL, Hindalco, Sona BLW, KPIT Tech: Check top buzzing stocks of the day

Market News

Piramal Pharma, CARE Ratings, HUL, Hindalco, Sona BLW, KPIT Tech: Check top buzzing stocks of the day

Upstox

4 min read | Updated on October 24, 2024, 12:51 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Shares of CARE Ratings were locked in the 20% upper circuit limit of ₹1,409.15 apiece on the BSE after the company announced its quarterly earnings on Wednesday. The company reported a 31% year-on-year (YoY) growth in consolidated profit after tax (PAT) at ₹46.88 crore for the July-September quarter (Q2) of financial 2024-25 (FY25). 

Piramal Pharma shares were trading 15% higher at ₹249.30 apiece on the BSE

Piramal Pharma shares were trading 15% higher at ₹249.30 apiece on the BSE

Buzzing Stocks: The domestic stocks were volatile in the afternoon trade on Thursday, October 24. The SENSEX was trading flat at 80,078.18 levels while the NSE NIFTY50 index was trading at 24,406.35 levels, down 29.15 points.
Here is a list of stocks that are buzzing in today's trade
HUL: Shares of Hindustan Unilever (HUL), the FMCG giant, tumbled nearly 8% to ₹2,453.10 apiece on the BSE after the company posted a weak set of numbers for the September quarter (Q2 FY25). 

Further, management commentary that consumer demand in urban markets is moderating unnerved investors. 

CARE Ratings: Shares of CARE Ratings were locked in the 20% upper circuit limit of ₹1,409.15 apiece on the BSE after the company announced its quarterly earnings on Wednesday.

The company reported a 31% year-on-year (YoY) growth in consolidated profit after tax (PAT) at ₹46.88 crore for the July-September quarter (Q2) of financial 2024-25 (FY25). 

CARE Ratings' revenue from operations grew 22% year-on-year (Y-o-Y) to ₹117.37 crore, while earnings before interest, taxes, depreciation, and amortisation (EBITDA) jumped 33% YoY to ₹55.72 crore, and margin stood at 47%, as per news reports. 

Sona BLW: Shares of Sona BLW Precision Forgings were trading 13% higher at ₹726.05 apiece on the BSE after the auto components maker reported growth in consolidated profit after tax (PAT) at ₹143.57-crore for the quarter ended September 30, 2024 (Q2 FY25).

Revenue from operations for the quarter under review was ₹922.18 crore, up 17% from ₹787.46 crore during Q2 FY24. 

Aster DM Healthcare: Aster DM Healthcare announced on Wednesday an 85% year-on-year (YoY) jump in net profit to ₹108 crore in Q2FY25. The company’s revenue climbed 16% YoY to ₹1,086 crore. Following the news, shares were trading 9% higher at ₹438.35 apiece on the BSE. 
KPIT Technologies: The stock was trading 12% lower at ₹1,412 on the BSE after the Q2 results announcement. 

Stock took a beating as the company's CEO said that the mobility industry, specifically the automotive sub-vertical, has been under pressure to keep up with the changing regulations, reduce the cost of vehicles, and meet the demands of the ever-changing consumer preferences in recent times.

Escorts Kubota: Shares were down over 6.5% at ₹3,456 apiece on the BSE after the company on Wednesday announced its decision to sell its railway equipment division to Sona BLW Precision Forgings Ltd for ₹1,600 crore. 

The companies have finalised a business transfer agreement, allowing the transfer of the railway equipment division (RED) as a going concern on a slump-sale basis.

VIP Industries: Shares of the company were trading 6% lower at ₹479.30 apiece on the BSE after the company posted a consolidated net loss of ₹33.05 crore for the second quarter, a significant drop from the ₹13.28 crore loss in the same period last year. Revenue saw a minor decline of 0.3%, standing at ₹544.26 crore versus Rs 546.09 crore YoY.
Hindalco: Shares of Hindalco Industries slumped as much as 7% to ₹666.80 apiece on the BSE on Thursday, October 24, a day after Constellium, a Paris-based global manufacturer, flagged softening of demand in automotive markets in North America and Europe.
Piramal Pharma: Piramal Pharma shares were trading 15% higher at ₹249.30 apiece on the BSE after the company on Thursday reported over four-fold increase in consolidated net profit at ₹23 crore for the second quarter ended September. 

The Mumbai-based company had reported a net profit of ₹5 crore in the July-September quarter of last fiscal.

Dr. Lal PathLabs: Shares were down 5% at ₹3,092.50 apiece on the BSE. The company on Wednesday said its consolidated profit after tax increased 18% year-on-year to ₹131 crore for the second quarter ended September 30, 2024.

Revenue increased to Rs 660 crore in the second quarter of this fiscal, as compared to Rs 601 crore in the year-ago period.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story